Clinical Trial Update: Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of d-MAPPS Ophthalmic Solution for chronic ocular graft-versus-host disease is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Graft-versus-host Disease

Drugs mentioned

• d-MAPPS Ophthalmic Solution

Snippet

Sponsor: Regenerative Ocular Immunobiologics LLC | Conditions: oGHVD | Phase 1, Phase 2 | Status: RECRUITING